Join the 200th Anniversary Celebration

Special Article

Major Causes of Death among Men and Women in China

Jiang He, M.D., Ph.D., Dongfeng Gu, M.D., Xigui Wu, M.D., Kristi Reynolds, Ph.D., M.P.H., Xiufang Duan, M.D., Chonghua Yao, M.D., Jialiang Wang, M.D., Chung-Shiuan Chen, M.S., Jing Chen, M.D., Rachel P. Wildman, Ph.D., M.P.H., Michael J. Klag, M.D., M.P.H., and Paul K. Whelton, M.D.

N Engl J Med 2005; 353:1124-1134September 15, 2005

Abstract

Background

With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China.

Methods

Baseline data on the participants' demographic characteristics, medical history, lifestyle-related risk factors, blood pressure, and body weight were obtained in 1991 with the use of a standard protocol. The follow-up evaluation was conducted in 1999 and 2000, with a follow-up rate of 93.4 percent.

Results

We documented 20,033 deaths in 1,239,191 person-years of follow-up. The mortality from all causes was 1480.1 per 100,000 person-years among men and 1190.2 per 100,000 person-years among women. The five leading causes of death were malignant neoplasms (mortality, 374.1 per 100,000 person-years), diseases of the heart (319.1), cerebrovascular disease (310.5), accidents (54.0), and infectious diseases (50.5) among men and diseases of the heart (268.5), cerebrovascular disease (242.3), malignant neoplasms (214.1), pneumonia and influenza (45.9), and infectious diseases (35.3) among women. The multivariate-adjusted relative risk of death and the population attributable risk for preventable risk factors were as follows: hypertension, 1.48 (95 percent confidence interval, 1.44 to 1.53) and 11.7 percent, respectively; cigarette smoking, 1.23 (95 percent confidence interval, 1.18 to 1.27) and 7.9 percent; physical inactivity, 1.20 (95 percent confidence interval, 1.16 to 1.24) and 6.8 percent; and underweight (body-mass index [the weight in kilograms divided by the square of the height in meters] below 18.5), 1.47 (95 percent confidence interval, 1.42 to 1.53) and 5.2 percent.

Conclusions

Vascular disease and cancer have become the leading causes of death among Chinese adults. Our findings suggest that control of hypertension, smoking cessation, increased physical activity, and improved nutrition should be important strategies for reducing the burden of premature death among adults in China.

Media in This Article

Figure 1Age-Standardized Mortality for the Five Leading Causes of Death from Vascular Disease (Panel A) and Malignant Neoplasms (Panel B) among 169,871 Study Participants.
Figure 2Age-Specific or Age-Standardized Mortality for the Five Leading Causes of Death among Study Participants 65 Years of Age or Older or Younger Than 65 Years (Panel A), Those Who Were Urban or Rural Residents (Panel B), and Those Living in Northern or Southern China (Panel C).
Article

Rapid economic development and the consequent improvement in living conditions, nutrition, and health care have resulted in declines in infant mortality and deaths from infectious diseases and therefore in increases in life expectancy in many developing countries, including China.1,2 In contrast, adverse changes in lifestyle (such as a high intake of dietary fat and increased physical inactivity) that tend to accompany industrialization and urbanization have become increasingly prevalent in these countries, and such changes may have increased the risk of chronic disease, including vascular disease and cancer.2-4 However, there are few data to support this epidemiologic transition of disease burden in developing countries.1 Unlike the situation in developed countries, in developing countries valid data on vital statistics are not usually available, owing to a lack of coherent systems for national registration of deaths.5

Cross-sectional studies, which provide a point estimate of disease burden, have indicated that the prevalence of chronic diseases and their risk factors has increased in developing countries.6-8 However, large, prospective cohort studies involving representative samples of the general population are needed to provide valid information on cause-specific mortality in the populations of these countries and to provide a scientific basis for rational allocation of health care resources. We conducted a large, prospective cohort study involving a representative sample of the general adult population 40 years of age and older in China to determine cause-specific mortality and to examine major preventable risk factors for total mortality.

Methods

Study Population

In 1991, a multistage, random cluster-sampling design was used to identify a representative sample of the general Chinese population 15 years of age and older from all 30 provinces for the China National Hypertension Survey.9 In 1999, investigators from each province were invited to participate in the China National Hypertension Survey Epidemiology Follow-up Study. Of the 30 provinces included in the initial study, 13 were not included in the follow-up study because contact information for the study participants in those provinces was not available. However, sampling was conducted independently within each province for the 1991 China National Hypertension Survey, and study participants in the 17 provinces that were included in the follow-up study were evenly distributed among the different geographic regions of the entire country representing various stages of economic development. Therefore, our study participants probably represent the general adult population in China. Overall, 83,533 men and 86,338 women who were 40 years of age or older at the time of their baseline examinations were eligible for participation in the follow-up study. Of these, a total of 158,666 participants or their proxies (93.4 percent) were identified and interviewed as part of the follow-up study.

Baseline Examination

Baseline data were collected during a single clinic visit by physicians and nurses trained in the use of standard methods and with stringent quality control.9 Data on demographic characteristics, medical history, and lifestyle-related risk factors were obtained. The assessment of physical activity involved only work-related physical activity. Cigarette smoking was defined as smoking at least one cigarette per day for one or more years. Data were collected on the amount and type of alcohol consumed during the previous year.

Three blood-pressure readings, measured with the use of a mercury sphygmomanometer according to a standard protocol, were obtained after the participant had been sitting quietly for five minutes.10 The first and fifth Korotkoff sounds were recorded as systolic and diastolic blood pressure, respectively. Hypertension was defined as one or more of the following: a mean systolic blood pressure greater than or equal to 140 mm Hg, a mean diastolic blood pressure greater than or equal to 90 mm Hg, or the use of antihypertensive medication.11 Body weight and height were measured when the participant was wearing light indoor clothing but not shoes, with the use of a standard protocol. Underweight was defined as a body-mass index (the weight in kilograms divided by the square of the height in meters) of less than 18.5 and overweight or obesity as a body-mass index of 25.0 or greater.12

Follow-up Data

Follow-up examinations, which were conducted in 1999 and 2000, included tracking participants or their proxies to a current address; conducting in-depth interviews to obtain information on the history of disease, hospitalizations, and death; and obtaining hospital records and death certificates. All deaths identified in interviews with participants' proxies were verified by death certificates obtained from the local departments of public health or police. If death occurred while a participant was hospitalized, the participant's hospital records, including medical history, findings on physical examination, laboratory findings, autopsy findings, and discharge diagnosis, were abstracted by trained staff using a standard form. In addition, photocopies of selected sections of the participant's inpatient record, discharge summary, electrocardiogram, and pathology reports were obtained.

An end-point assessment committee in each province reviewed and confirmed (or rejected) the hospital's discharge diagnosis and the cause of death on the basis of the abstracted information, using prespecified criteria. A study-wide end-point assessment committee at the Chinese Academy of Medical Sciences in Beijing reviewed all death records and determined the final underlying cause of death. Two committee members independently of each other verified the cause of death, and discrepancies were adjudicated by discussion involving other members of the committee. All members of the local and study-wide end-point assessment committees were unaware of information about the baseline risk factors of the study participants. The causes of death were coded according to the International Classification of Diseases, Ninth Revision (ICD-9).

The current study was approved by the Tulane University Health Sciences Center's institutional review board. Written informed consent was obtained from all study participants at their follow-up visit.

Statistical Analysis

Person-years of follow-up were calculated for each study participant and grouped according to sex and to age in five-year categories. Age-standardized mortality was calculated with the use of the five-year age-specific mortality and the age distribution of the Chinese population, obtained from the 2000 census data. Age-standardized cause-specific mortality was calculated separately for men and women, for residents of urban and rural areas, and for those living in northern and southern China, where diet and other lifestyle-related risk factors were different.13 For example, the dietary intake of sodium was higher among residents of northern China, as compared with those of southern China, whereas physical activity was lower.

Cox proportional-hazards models were used to estimate the relative risk of death for preventable risk factors. Heavy alcohol consumption (i.e., three or more drinks per day) was not related to an increase in total mortality, but we included alcohol consumption as a covariate because it was strongly related to other risk factors included in the study. A self-reported history of diabetes was also included as a covariate, because it was significantly associated with total mortality. Because the total mortality for current and former cigarette smokers was similar, the relative risk of ever having smoked as compared with never having smoked was calculated. As compared with normal weight (a body-mass index of 18.5 to 24.9), overweight or obesity was not associated with increased mortality. In contrast, because underweight was associated with increased total mortality, the relative risk of underweight was estimated.

In the final multivariate models, all preventable risk factors, such as hypertension, cigarette smoking, physical inactivity, and underweight, as well as the covariates, including baseline age, sex, the presence or absence of a high-school education, alcohol consumption, self-reported history of diabetes, geographic region (north vs. south), and urbanization (urban vs. rural residence), were included simultaneously. The population attributable risk, measured as the percentage of deaths that could be prevented in the total population if the risk factor of interest were eliminated, was calculated.14 Statistical analyses were conducted with the use of SAS software, version 8 (SAS Institute).

Results

The baseline characteristics of the study participants according to sex are presented in Table 1Table 1Baseline Characteristics of the 169,871 Study Participants.. Overall, 49.2 percent of the study participants were men and 50.8 percent were women. The mean age was 55.8 years, with a range from 40 to 105 years.

During an average follow-up period of 8.3 years (1,239,191 person-years), we documented 20,033 deaths. The total mortality was 1345.2 per 100,000 person-years (1480.1 per 100,000 person-years among men and 1190.2 per 100,000 person-years among women). Age-standardized mortality and the percentage of total deaths for the 10 leading causes of death are shown in Table 2Table 2Age-Standardized Mortality and the Percentage of Total Deaths for the 10 Leading Causes of Death in China.. The three leading causes of death (diseases of the heart, malignant neoplasms, and cerebrovascular disease) accounted for 66.0 percent of deaths from all causes (68.7 percent in men and 62.6 percent in women).

The five leading causes of death from vascular disease were cerebrovascular disease (mortality, 276.9 per 100,000 person-years), chronic pulmonary heart disease (137.6), coronary heart disease (85.5), heart failure (14.5), and rheumatic heart disease (9.7). (The International Classification of Diseases, 9th Revision, code for chronic pulmonary heart disease is 416, and the codes for rheumatic heart disease are 391 through 398.) The rank order of deaths from vascular disease was consistent in men and women (Figure 1Figure 1Age-Standardized Mortality for the Five Leading Causes of Death from Vascular Disease (Panel A) and Malignant Neoplasms (Panel B) among 169,871 Study Participants.). The five leading causes of death from cancer were malignant neoplasms of the lung (mortality, 71.5 per 100,000 person-years), liver (54.7), stomach (48.6), esophagus (31.3), and colon and rectum (17.4). However, stomach cancer was the second leading cause of death from cancer among women (Figure 1). Among women, mortality from malignant neoplasm of the breast was 11.1 per 100,000 person-years and from malignant neoplasm of the uterus was 18.0 per 100,000 person-years.

Age-specific mortality for the five leading causes of death (40 to 64 years of age vs. 65 years of age or more) and age-standardized mortality according to urbanization (urban vs. rural) and geographic region (north vs. south) are shown in Figure 2Figure 2Age-Specific or Age-Standardized Mortality for the Five Leading Causes of Death among Study Participants 65 Years of Age or Older or Younger Than 65 Years (Panel A), Those Who Were Urban or Rural Residents (Panel B), and Those Living in Northern or Southern China (Panel C).. The pattern of cause-specific mortality was consistent between men and women (data not shown). Overall, diseases of the heart, malignant neoplasms, and cerebrovascular disease accounted for more than half of deaths from all causes in each subgroup. For example, the percentages of total deaths due to these causes were 62.1 percent among older study participants and 71.4 percent among younger participants, 70.3 percent among urban residents and 61.7 percent among rural residents, and 75.2 percent among those living in northern China and 53.9 percent among those living in southern China. Deaths from diseases of the heart and cerebrovascular disease were significantly higher in northern China than in southern China.

The multivariate adjusted relative risk and population attributable risk of death for major preventable risk factors are presented in Table 3Table 3Relative Risk and Population Attributable Risk of Death Associated with Hypertension, Cigarette Smoking, Physical Inactivity, and Underweight in China.. Hypertension appeared to be responsible for 11.7 percent of the total mortality in the study population. This estimated population attributable risk did not vary substantially according to sex, urbanization, or geographic region. Cigarette smoking was responsible for 7.9 percent of the total mortality; the estimated risk was higher among men than among women and higher among urban residents than among rural residents. Physical inactivity accounted for 6.8 percent of the total mortality, with the estimated risk of death being slightly higher among men than among women and higher among urban residents than among rural residents (especially among women). Underweight accounted for 5.2 percent of the total mortality; the estimated risk of death was consistent between men and women, but it was higher among rural residents than among urban residents, and higher among those living in southern China than among those in northern China. The association between underweight and an increased risk of death remained significant after the exclusion of study participants who were current or former smokers; those who had prevalent cardiovascular disease, stroke, cancer, or end-stage renal disease; those who had chronic obstructive pulmonary disease at the baseline examination; or those who died during the first three years of follow-up.

Discussion

Our study indicates that diseases of the heart, malignant neoplasms, and cerebrovascular disease are the leading causes of death in the Chinese population of adults 40 years of age and older. Together, these causes accounted for approximately two thirds of the total mortality in the study population.

These findings have important public health implications. Historically, infant mortality and death from infectious diseases have been the major causes of death in developing countries.15 Even in recent years, the public health priorities, which are set by government policymakers in these countries and by international agencies, have been to reduce infant and maternal mortality and to control infectious diseases.16,17 The results of the present study call for serious attention to be given to the consequences of chronic diseases in developing countries.

Few previous studies have reported cause-specific mortality in China.18-20 According to vital statistics available for 13 cities in China, diseases of the respiratory system, acute infectious diseases, and tuberculosis were the leading causes of death in 1957, accounting for 16.9 percent, 7.9 percent, and 7.5 percent of the total deaths, respectively. In the same period, diseases of the heart, cerebrovascular disease, and malignant neoplasms were the fifth, sixth, and seventh leading causes of death, accounting for 6.6 percent, 5.5 percent, and 5.2 percent of total deaths, respectively.18 Although there are differences in the reporting and classification of deaths between these studies and ours, our data support the notion that a transition in disease burden has occurred in China.

Typically, chronic diseases have been considered a public health problem only in developed countries and among the elderly.3 Our study suggests that chronic diseases affect a much higher proportion of people during their prime working years in China, as compared with developed countries.21 For example, the mortality was 265.9 per 100,000 person-years for malignant neoplasm, 171.5 per 100,000 person-years for cerebrovascular disease, and 159.1 per 100,000 person-years for diseases of the heart in the Chinese population 40 to 64 years of age in our study. In the U.S. population 45 to 64 years of age, the corresponding mortality rates in 2002 were 215.1, 23.8, and 150.5 per 100,000 person-years.21 The economic impact of chronic disease on society, including the direct costs of health care and the indirect costs resulting from lost productivity due to illness and death, is substantial. The higher number of deaths due to chronic disease among rural residents, as compared with urban residents, in China is a particular concern because of the scarce health care resources available in rural China and the fact that infant mortality and infectious diseases remain serious public health challenges in this setting.

Hypertension is the most common risk factor for cardiovascular and cerebrovascular diseases worldwide.6 The prevalence of hypertension has been increasing in China in recent decades, whereas rates of awareness, treatment, and control remain unacceptably low.22 Our results indicate that hypertension is the leading preventable risk factor for death among Chinese adults 40 years of age and older; total mortality was 48 percent higher among study participants who had hypertension than among those who did not have hypertension. Furthermore, our findings suggest that the prevention and control of hypertension could reduce the total mortality by 11.7 percent in the total study population. These results are consistent with other analyses that have suggested that hypertension is the leading risk factor for the global burden of disease.3,4

Our study also indicates that cigarette smoking is a major preventable risk factor for death in China. If cigarette smoking were eliminated, we estimate that the total mortality could be reduced by 10.0 percent among men and by 3.5 percent among women in China. This estimate does not take into account the possible effects of passive smoking.23 Our data are in agreement with those from several prospective cohort studies and case – control studies conducted in China, which have documented that cigarette smoking increases the mortality from cancer, respiratory disease, and cardiovascular disease.24-28 Although our study did not detect a significant difference in total mortality between current and former smokers, epidemiologic investigations indicate that a reduction in mortality occurs gradually after smoking is stopped.29 In our study, the average interval since a participant had stopped smoking was only seven years. In addition, we found that physical inactivity was related to an increase in total mortality in China. These findings suggest that increasing physical activity could play an important role in the reduction of total mortality in China.

Finally, our study identified underweight as a preventable risk factor for total mortality. The population attributable risk for underweight was slightly higher among rural residents than among urban residents. Underweight, which may reflect malnutrition, was reported as the leading cause of the disease burden in developing countries with high mortality and an important contributor to the burden of disease in developing countries with low mortality, in a recent report from the World Health Organization.30

Some limitations of our study should be noted. We did not collect data on dietary patterns, leisure-time physical activity, serum lipid levels or results of other laboratory tests, or changes in body weight (or changes in other risk factors) over time. Therefore, the contribution of these factors to total mortality could not be estimated. A diagnosis of diabetes was based only on self-reports; it is likely that this resulted in an underestimation of the population attributable risk of death due to diabetes. The lack of autopsy data to confirm causes of death may have introduced some misclassification bias. However, we maintained a very high follow-up rate and used a stringent approach to classifying outcomes on the basis of medical records.

In summary, our study indicates that diseases of the heart, malignant neoplasms, and cerebrovascular disease account for approximately two thirds of the total deaths in the Chinese population 40 years of age and older. Furthermore, hypertension, cigarette smoking, physical inactivity, and underweight are leading preventable risk factors for death. Control of hypertension, smoking cessation, increased physical activity, and improved nutrition are likely to be important strategies for reducing the burden of mortality in China.

Supported by grants from the American Heart Association (9750612N), the National Heart, Lung, and Blood Institute (U01 HL072507), and the Chinese Academy of Medical Sciences (Beijing).

Drs. He and Gu contributed equally to this work.

Source Information

From the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine (J.H., K.R., C.-S.C., J.C., R.P.W., P.K.W.), and the Department of Medicine, Tulane University School of Medicine (J.H., J.C., P.K.W.) — both in New Orleans; the Cardiovascular Institute, Fuwai Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College, and the National Center for Cardiovascular Disease Control and Research, Beijing (D.G., X.W., X.D.); Anzhen Hospital, Capital University of Medical Sciences, Beijing (C.Y.); West China College of Medicine, Sichuan University, Chendu, China (J.W.); and the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (M.J.K.).

Address reprint requests to Dr. He at the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1430 Tulane Ave., Mail Stop SL18, New Orleans, LA 70112, or at .

All investigators participating in this study are listed in the Appendix.

Appendix

The following investigators participated in this study: Steering Committee: J. He (coprincipal investigator), D. Gu (coprincipal investigator), J. Chen, R. Hui, M.J. Klag, L. Kong, S. Tao, J. Wang, P.K. Whelton, X. Wu, and C. Yao; Participating Institutions and Principal Staff: Tulane University Health Sciences Center, New Orleans: C.-S. Chen, J. Chen, J. He, K. Reynolds, P.K. Whelton, R.P. Wildman; Johns Hopkins Bloomberg School of Public Health, Baltimore: M.J. Klag; Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing: X. Duan, W. Gan, D. Gu, G. Huang, S. Tao, X. Wu, W. Yang, J. Zhao; Chinese Ministry of Health, Beijing: L. Kong; Tianjin City Bureau of Public Health, Tianjin, China: G. Zheng; Tianjin City Center of Disease Control and Prevention, Tianjin, China: G. Song; Guangdong Provincial People's Hospital and Cardiovascular Institute, Guangdong, China: X. Liu, J. Mai; Anzhen Hospital, Capital University of Medical Sciences, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing: C. Yao; Capital Iron and Steel Company's Hospital, Beijing: X. Yu; Fangshan District Hospital, Beijing: X. Xu; Zhejiang Provincial Center for Cardiovascular Disease Prevention and Research, Zhejiang, China: H. Jin, X. Tang; Fujian Provincial People's Hospital, Fujian, China: X. Pu, L. Yu; Shandong Provincial Academy of Medical Sciences, Shandong, China: S. Zhang; Guangxi Medical University, Guangxi, China: L. Zhu; Xi'an Jiaotong University Medical School, Shanxi, China: J. Mo; Henan Provincial Academy of Medical Sciences, Henan, China: J. Guo; Tongji Medical College and School of Public Health, Huazhong University of Science and Technology, Hubei, China: Y. Hu, Y. Yu; Sichuan Provincial Center of Disease Control and Prevention, Sichuan, China: X. Wu; West China College of Medicine, Sichuan University, Sichuan, China: J. Wang; Nanjing Medical University, Jiangsu, China: H. Shen, C. Yao; Beihua University Medical School, Jilin, China: L. Xu, G. Zhao; Inner Mongolia Hospital, Inner Mongolia, China: X. Gao, J. Zhou; First Clinical College of Harbin Medical University, Heilongjiang, China: Y. Li; Daqing City Center of Disease Control and Prevention, Heilongjiang, China: Z. Li; Hebei Provincial Academy of Medical Sciences, Hebei, China: H. Zhang; Zhongshan Hospital and Institute of Cardiovascular Diseases, Fudan University, Shanghai, China: X. Pan.

References

References

  1. 1

    Sen K, Bonita R. Global health status: two steps forward, one step back. Lancet 2000;356:577-582
    CrossRef | Web of Science | Medline

  2. 2

    Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-2753
    CrossRef | Web of Science | Medline

  3. 3

    Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291:2616-2622
    CrossRef | Web of Science | Medline

  4. 4

    Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360
    CrossRef | Web of Science | Medline

  5. 5

    The world health report 1999: making a difference. Geneva: World Health Organization, 1999.

  6. 6

    Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-223
    Web of Science | Medline

  7. 7

    King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
    CrossRef | Web of Science | Medline

  8. 8

    He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004;110:405-411
    CrossRef | Web of Science | Medline

  9. 9

    Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol 1995;52:39-44
    CrossRef | Web of Science | Medline

  10. 10

    Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers. Circulation 1988;77:501A-514A
    Medline

  11. 11

    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572[Erratum, JAMA 2003;290:197.]
    CrossRef | Web of Science | Medline

  12. 12

    Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults -- The Evidence Report: National Institutes of Health. Obes Res 1998;6:Suppl 2:51S-209S[Erratum, Obes Res 1998;6:464.]
    Medline

  13. 13

    Huang Z, Wu X, Stamler J, et al. A north-south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report from the PRC-USA Collaborative Study of Cardiovascular Epidemiology. J Hypertens 1994;12:1103-1112
    CrossRef | Web of Science | Medline

  14. 14

    Kahn HA, Sempos CT. Attributable risk. In: Kahn HA, Sempos CT, eds. Statistical methods in epidemiology. New York: Oxford University Press, 1989:73-84.

  15. 15

    Gwatkin DR, Guillot M, Heuveline P. The burden of disease among the global poor. Lancet 1999;354:586-589
    CrossRef | Web of Science | Medline

  16. 16

    Group of Seventy-Seven. Final Communiqué adopted by the thirty-fourth Meeting of Chairmen/Coordinators of the Chapters of the Group of 77, Geneva, 26-27 June 2003 (press release). (Accessed August 22, 2005, at http://www.g77.org/news/pr062703.htm.)

  17. 17

    United Nations Development Programme (UNDP). Millennium development goals. (Accessed August 29, 2005, at http://www.undp.org/mdg/abcs.html.)

  18. 18

    Ministry of Public Health, People's Republic of China. Health statistics information in China, 1949-1988. Beijing: Ministry of Public Health, 1990. (In Chinese.)

  19. 19

    Zhang Z. Major causes of deaths in Harbin city, 1957-1986. Chin Health Stat 1991;8:39-41

  20. 20

    Li Y, Gu S, He L. Statistical analysis of causes of deaths among Shanghai county residents. Chin Health Stat 1985;2:18-21

  21. 21

    Kochanek KD, Smith BL. Deaths: preliminary data for 2002. National vital statistics reports. Vol. 52. No. 13. Hyattsville, Md.: National Center for Health Statistics, 2004. (Accessed August 22, 2005, at http://www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr52_13.pdf.)

  22. 22

    Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002;40:920-927
    CrossRef | Web of Science | Medline

  23. 23

    Gu D, Wu X, Reynolds K, et al. Cigarette smoking and exposure to environmental tobacco smoke in China: the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health 2004;94:1972-1976
    CrossRef | Web of Science | Medline

  24. 24

    Yuan JM, Ross PK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai, China: a prospective male cohort study. JAMA 1996;275:1646-1650
    CrossRef | Web of Science | Medline

  25. 25

    Lam TH, He Y, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA 1997;278:1505-1508[Erratum, JAMA 1998;279:1350.]
    CrossRef | Web of Science | Medline

  26. 26

    Chen ZM, Xu Z, Collins R, Li WX, Peto R. Early health effects of the emerging tobacco epidemic in China: a 16-year prospective study. JAMA 1997;278:1500-1504[Erratum, JAMA 1999;281:1893.]
    CrossRef | Web of Science | Medline

  27. 27

    Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:1411-1422
    CrossRef | Web of Science | Medline

  28. 28

    Niu SR, Yang GH, Chen ZM, et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ 1998;317:1423-1424
    CrossRef | Web of Science | Medline

  29. 29

    Hays JT, Hurt RD, Dale LC. Smoking cessation. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, eds. Prevention of myocardial infarction. New York: Oxford University Press, 1996:99-129.

  30. 30

    World Health Organization. The world health report 2002 — reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.

Citing Articles (197)

Citing Articles

  1. 1

    Elena V Kuklina, Xin Tong, Mary G George, Pooja Bansil. (2012) Epidemiology and prevention of stroke: a worldwide perspective. Expert Review of Neurotherapeutics 12:2, 199-208
    CrossRef

  2. 2

    Lijun Zhang, Zhirong Guo, Ming Wu, Xiaoshu Hu, Yanying Xu, Zhengyuan Zhou. (2012) Interaction of smoking and metabolic syndrome on cardiovascular risk in a Chinese cohort. International Journal of Cardiology
    CrossRef

  3. 3

    Qian Zhou, Vivian Wai Yan Lui, Cecilia Pik Yuk Lau, Suk Hang Cheng, Margaret Heung Ling Ng, Yijun Cai, Stephen Lam Chan, Winnie Yeo. (2012) Sustained Antitumor Activity by Co-Targeting mTOR and the Microtubule with Temsirolimus/Vinblastine Combination in Hepatocellular Carcinoma. Biochemical Pharmacology
    CrossRef

  4. 4

    Guang-Hui Dong, Da Wang, Miao-Miao Liu, Yu-Qin Liu, Yang Zhao, Mingan Yang, Xiu-Jun Meng, Shen Tian, Xin Meng, Hai-Yan Zhang. (2012) Sex difference of the prevalence and risk factors associated with prehypertension among urban Chinese adults from 33 communities of China. Journal of Hypertension1
    CrossRef

  5. 5

    Zhigang Liu, Ruifang Sun, Weidong Lü, Chengxue Dang, Yangrong Song, Cheng Wang, Xi Zhang, Le Han, Hao Cheng, Wei Gao, Jia Liu, Guangyan Lei. (2011) The -938A/A genotype of BCL2 gene is associated with esophageal cancer. Medical Oncology
    CrossRef

  6. 6

    Zhi-Yin Yang, Zhen Yang, Lifang Zhu, Chengxuan Qiu. (2011) Human Behaviors Determine Health: Strategic Thoughts on the Prevention of Chronic Non-communicable Diseases in China. International Journal of Behavioral Medicine 18:4, 295-301
    CrossRef

  7. 7

    Yebin Tao, Liuju Zhong, Xiaoliang Huang, Shou-En Lu, Yi Li, Lingzhen Dai, Yuanhang Zhang, Tong Zhu, Wei Huang. (2011) Acute mortality effects of carbon monoxide in the Pearl River Delta of China. Science of The Total Environment 410:411, 34-40
    CrossRef

  8. 8

    Yongfeng Wang, Jin Cheng, Chunhui Xu, Shuang Liu, Suzhen Jiang, Qiang Xu, Xiangmei Chen, Hui Zhuang, Fengmin Lu. (2011) Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma. Liver Internationaln/a-n/a
    CrossRef

  9. 9

    Zhong Chen, Fangyi Xie, Genshan Ma, Yi Feng, Qi Qian, Naifeng Liu. (2011) Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population. Molecular Biology Reports 38:8, 5085-5091
    CrossRef

  10. 10

    Chuanxi Wang, Bao Song, Wei Song, Jie Liu, Aimin Sun, Dehua Wu, Huiming Yu, Jianping Lian, Longhua Chen, Junqing Han. (2011) Underexpressed microRNA-199b-5p targets Hypoxia-Inducible Factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 26:11, 1630-1637
    CrossRef

  11. 11

    Lili Ma, Kerry Grann, Mei Li, Zhuoqin Jiang. (2011) A Pilot Study to Evaluate the Effect of Soy Isolate Protein on the Serum Lipid Profile and Other Potential Cardiovascular Risk Markers in Moderately Hypercholesterolemic Chinese Adults. Ecology of Food and Nutrition 50:6, 473-485
    CrossRef

  12. 12

    Yao Lu, Peifeng Hu, Donald J. Treiman. (2011) Migration and depressive symptoms in migrant-sending areas: findings from the survey of internal migration and health in China. International Journal of Public Health
    CrossRef

  13. 13

    Xiao-Qian Chen, Juan-Ru He, Hui-Yun Wang. (2011) Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma. Medical Oncology
    CrossRef

  14. 14

    Zhen-Yu Xiao, Jin-Bin Jia, Lin Chen, Wei Zou, Xiao-Ping Chen. (2011) Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma. Medical Oncology
    CrossRef

  15. 15

    Shen Tian, Guang-Hui Dong, Da Wang, Miao-Miao Liu, Qiao Lin, Xiu-Jun Meng, Li-Xia Xu, Hua Hou, Yu-Feng Ren. (2011) Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE Study. Hypertension Research 34:10, 1087-1092
    CrossRef

  16. 16

    Pei Wang, Wei-Wei Tian, Jie Song, Yun-Feng Guan, Chao-Yu Miao. (2011) Deficiency of NG2+ Cells Contributes to the Susceptibility of Stroke-Prone Spontaneously Hypertensive Rats. CNS Neuroscience & Therapeutics 17:5, 327-332
    CrossRef

  17. 17

    Z. Chen, J. Chen, R. Collins, Y. Guo, R. Peto, F. Wu, L. Li, . (2011) China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. International Journal of Epidemiology
    CrossRef

  18. 18

    Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. (2011) Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with Transplantation. Pathology & Oncology Research
    CrossRef

  19. 19

    Xiang Zhou, Weiting Xu, Jianchang Chen. (2011) The 981C>T polymorphism in protein tyrosine phosphatase 1B is associated with decreased risk of coronary artery disease in Chinese Han population. Atherosclerosis 218:1, 147-150
    CrossRef

  20. 20

    Chun Yu Li, Hae-Ra Han, Jiyun Kim, Miyong T. Kim. (2011) Factors Related to Risk of Cardiovascular Disease Among Older Korean Chinese With Hypertension. Asian Nursing Research 5:3, 164-169
    CrossRef

  21. 21

    Yong Zhang, Guoyu Yu, Ping Jiang, Yang Xiang, Wenliang Li, Wenhui Lee, Yun Zhang. (2011) Decreased expression of protease-activated receptor 4 in human gastric cancer. The International Journal of Biochemistry & Cell Biology 43:9, 1277-1283
    CrossRef

  22. 22

    David Faeh, Julia Braun, Silvan Tarnutzer, Matthias Bopp. (2011) Obesity but not overweight is associated with increased mortality risk. European Journal of Epidemiology 26:8, 647-655
    CrossRef

  23. 23

    Han Bing, Wu Li-Qun, Ma Xiang, Wang Zheng-Hua, Li Jin-Peng, Bi Chong-Yao, Yong Sun. (2011) Synergistic Effect of IFN-γ Gene on LIGHT-induced Apoptosis in HepG2 Cells via Down Regulation of Bcl-2. Artificial Cells, Blood Substitutes and Biotechnology 39:4, 228-238
    CrossRef

  24. 24

    Paolo Palatini, Lucio Mos, Massimo Santonastaso, Francesca Saladini, Elisabetta Benetti, Paolo Mormino, Alessandra Bortolazzi, Susanna Cozzio. (2011) Premenopausal Women Have Increased Risk of Hypertensive Target Organ Damage Compared with Men of Similar Age. Journal of Women's Health 20:8, 1175-1181
    CrossRef

  25. 25

    G. W. Huang, X. Ding, S. L. Chen, L. Zeng. (2011) Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. Journal of Cancer Research and Clinical Oncology 137:8, 1213-1218
    CrossRef

  26. 26

    Xiaoyan Lei, Nina Yin, Yaohui Zhao. (2011) Socioeconomic status and chronic diseases: The case of hypertension in China. China Economic Review
    CrossRef

  27. 27

    Mingliang Gu, Yue Qi, Mingping Li, Wenquan Niu. (2011) Association of Body Mass Index and Alcohol Intake with Hypertension Subtypes Among HAN Chinese. Clinical and Experimental Hypertension1-7
    CrossRef

  28. 28

    Chen Suo, Haiyan Xu, Chiea-Chuen Khor, Rick TH Ong, Xueling Sim, Jieming Chen, Wan-Ting Tay, Kar-Seng Sim, Yi-Xin Zeng, Xuejun Zhang, Jianjun Liu, E-Shyong Tai, Tien-Yin Wong, Kee-Seng Chia, Yik-Ying Teo. (2011) Natural positive selection and north–south genetic diversity in East Asia. European Journal of Human Genetics
    CrossRef

  29. 29

    Weiqing Wang, Ruifang Bu, Qing Su, Jianying Liu, Guang Ning. (2011) Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. Expert Opinion on Pharmacotherapy1-9
    CrossRef

  30. 30

    Qingfeng Hu, Weili Zhu, Yili Zhu, Lu Zheng, Richard L. Hughson. (2011) Acute effects of warm footbath on arterial stiffness in healthy young and older women. European Journal of Applied Physiology
    CrossRef

  31. 31

    Xiu-Jun Meng, Guang-Hui Dong, Da Wang, Miao-Miao Liu, Qiao Lin, Shen Tian, Li-Xia Xu, Hua Hou, Yu-Feng Ren, Yungling L Lee. (2011) Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. Journal of Hypertension 29:7, 1303-1310
    CrossRef

  32. 32

    Zhi-ming Wu, Chun Dai, Ying Huang, Cui-fang Zheng, Qiong-zhu Dong, Guan Wang, Xiao-wen Li, Xiao-fei Zhang, Bin Li, Gang Chen. (2011) Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacologica Sinica 32:7, 939-946
    CrossRef

  33. 33

    Mary W Roederer, Francisco Sanchez-Giron, Kusha Kalideen, William Kudzi, Howard L McLeod, Wei Zhang. (2011) Pharmacogenetics and rational drug use around the world. Pharmacogenomics 12:6, 897-905
    CrossRef

  34. 34

    Paula H Palmer, Bin Xie, Liming Lee, Chih-Ping Chou, Ping Sun, Bree Hemingway, C. Anderson Johnson. (2011) The China Seven Cities Study (CSCS) consortium: adapting evidence-based prevention science from west to east. Translational Behavioral Medicine 1:2, 283-288
    CrossRef

  35. 35

    E. Uretsky. (2011) The risk of success: cultural determinants of chronic disease and sexually transmitted infections among urban Chinese men. Health Promotion International 26:2, 212-219
    CrossRef

  36. 36

    Lee-Ching Hwang, Su-Chiu Chen, Chien-Jen Chen. (2011) Increased Risk of Mortality From Overweight and Obesity in Middle-aged Individuals From Six Communities in Taiwan. Journal of the Formosan Medical Association 110:5, 290-298
    CrossRef

  37. 37

    Duowu Zou, Jia He, Xiuqiang Ma, Wenbin Liu, Jie Chen, Xingang Shi, Ping Ye, Yanfang Gong, Yanfang Zhao, Rui Wang, Xiaoyan Yan, Xiaohua Man, Li Gao, John Dent, Joseph Sung, Börje Wernersson, Saga Johansson, Zhaoshen Li. (2011) Helicobacter pylori infection and gastritis: The Systematic Investigation of gastrointestinaL diseases in China (SILC). Journal of Gastroenterology and Hepatology 26:5, 908-915
    CrossRef

  38. 38

    Yong Zhang, Jing-chen Ma, Shun-xiang Qi, Feng Wang, Chong Zhao, Sheng-li Bi. (2011) Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities. Vaccine 29:22, 3905-3908
    CrossRef

  39. 39

    Shang-Cheng Zhou, Le Cai, Jing Wang, Shao-guo Cui, Yun Chai, Bing Liu, Chong-Hua Wan. (2011) Measuring the burden of disease using disability-adjusted life years in Shilin County of Yunnan Province, China. Environmental Health and Preventive Medicine 16:3, 148-154
    CrossRef

  40. 40

    Mo Yin Mok, Chak Sing Lau, Sonny Sau Hin Chiu, Annette Wai Kwan Tso, Yi Lo, Lawrence Siu Chun Law, Ka Fung Mak, Woon Sing Wong, Peh Lan Khong, Karen Siu Ling Lam. (2011) Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis & Rheumatism 63:5, 1387-1395
    CrossRef

  41. 41

    -Wei Du Hong, -Yue Li Jia, He Yao. (2011) Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis. Journal of Geriatric Cardiology 8:1, 24-30
    CrossRef

  42. 42

    Patricia Van der Niepen, Dierik Verbeelen. (2011) Gender and hypertension management: A sub-analysis of the I-inSYST survey. Blood Pressure 20:2, 69-76
    CrossRef

  43. 43

    P Isaakidis, M-E Raguenaud, C Say, H De Clerck, C Khim, R Pottier, S Kuoch, U Prahors, S Chour, W Van Damme, T Reid. (2011) Treatment of hypertension in rural Cambodia: results from a 6-year programme. Journal of Human Hypertension 25:4, 241-249
    CrossRef

  44. 44

    Jin Zhang, Yan Li, Yan Wang, Wenquan Niu, Yi Zhang, Pingjin Gao, Liyun Zhang, Huawei Lin, Kemin Chen, Dingliang Zhu. (2011) Arterial Stiffness and Asymptomatic Intracranial Large Arterial Stenosis and Calcification in Hypertensive Chinese. American Journal of Hypertension 24:3, 304-309
    CrossRef

  45. 45

    Ta-Chen Su, Szu-Ying Chen, Chang-Chuan Chan. (2011) Progress of Ambient Air Pollution and Cardiovascular Disease Research in Asia. Progress in Cardiovascular Diseases 53:5, 369-378
    CrossRef

  46. 46

    Jie Huang, Jinming Yu, Dayi Hu, Yangfeng Wu, Jingqian Lu, Yi Li, Ying Huang, Stanley P. Azen, Laurie D. Dustin, Robert C. Detrano. (2011) The Farther From Town the Lower the Blood Pressure: Report From Rural Yunnan Province. American Journal of Hypertension 24:3, 335-339
    CrossRef

  47. 47

    Wan C Tan. (2011) Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions. Current Opinion in Pulmonary Medicine 17:2, 56-61
    CrossRef

  48. 48

    Haidong Kan, Renjie Chen, Shilu Tong. (2011) Ambient air pollution, climate change, and population health in China. Environment International
    CrossRef

  49. 49

    Yong Wang. (2011) Analysis of plasma metabonomics of mini-swines with qi deficiency and blood stasis syndrome due to chronic myocardial ischemia. Journal of Chinese Integrative Medicine 9:2, 158-164
    CrossRef

  50. 50

    Jie Cao, Chunxue Yang, Jianxin Li, Renjie Chen, Bingheng Chen, Dongfeng Gu, Haidong Kan. (2011) Association between long-term exposure to outdoor air pollution and mortality in China: A cohort study. Journal of Hazardous Materials 186:2-3, 1594-1600
    CrossRef

  51. 51

    Jie Wu, Wen-hua Yan, Ling Qiu, Xin-qi Chen, Xiu-zhi Guo, Wei Wu, Liang-yu Xia, Xu-zhen Qin, Yan-hong Liu, Hai-tao Ding, Shao-mei Han, Cheng-li Xu, Guang-jin Zhu. (2011) High prevalence of coexisting prehypertension and prediabetes among healthy adults in northern and northeastern China. BMC Public Health 11:1, 794
    CrossRef

  52. 52

    Jingfeng Ji, Enchun Pan, Jianxin Li, Jichun Chen, Jie Cao, Dongling Sun, Xiangfeng Lu, Shufeng Chen, Dongfeng Gu, Xiufang Duan, Xigui Wu, Jianfeng Huang. (2011) Classical risk factors of cardiovascular disease among Chinese male steel workers: a prospective cohort study for 20 years. BMC Public Health 11:1, 497
    CrossRef

  53. 53

    Yuan Liang, Jia-Li Liu, Yan Wu, Zhen-Yong Zhang, Rong Wu. (2011) Cyclooxygenase-2 Polymorphisms and Susceptibility to Esophageal Cancer: A Meta-Analysis. The Tohoku Journal of Experimental Medicine 223:2, 137-144
    CrossRef

  54. 54

    Hao Zhang, Meili Sun, Tao Sun, Cheng Zhang, Xiao Meng, Yun Zhang, Jianmin Yang. (2011) Association between Angiotensin II Type 1 Receptor Gene Polymorphisms and Ischemic Stroke: A Meta-Analysis. Cerebrovascular Diseases 32:5, 431-438
    CrossRef

  55. 55

    Jing Fu, Yao Chen, Jie Cao, Tao Luo, You-Wen Qian, Wen Yang, Yi-Bin Ren, Bo Su, Guang-Wen Cao, Yuan Yang, Yi-Qun Yan, Feng Shen, Meng-Chao Wu, Gen-Sheng Feng, Hong-Yang Wang. (2011) p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways. Hepatology 53:1, 181-192
    CrossRef

  56. 56

    Jianping Shen, Musang Liu, Min Zhou, Wenzhong Li. (2011) Causes of death among active leprosy patients in China. International Journal of Dermatology 50:1, 57-60
    CrossRef

  57. 57

    Pei Wang, Paul M Vanhoutte, Chao-Yu Miao. (2011) Visfatin and Cardio-Cerebro-Vascular Disease. Journal of Cardiovascular Pharmacology1
    CrossRef

  58. 58

    Hao Chen, Wei-Dong Jia, Jian-Sheng Li, Wei Wang, Ge-Liang Xu, Jin-Liang Ma, Wei-Hua Ren, Yong-Sheng Ge, Ji-Hai Yu, Wen-Bin Liu, Chuan-Hai Zhang, Yong-Cang Wang. (2010) Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Medical Oncology
    CrossRef

  59. 59

    Qin Cui, Xianxia Ju, Tao Yang, Mei Zhang, Wei Tang, Qi Chen, Yong Hu, Joseph V. Haas, Jason S. Troutt, Richard T. Pickard, Ryan Darling, Robert J. Konrad, Hongwen Zhou, Guoqing Cao. (2010) Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population. Atherosclerosis 213:2, 632-636
    CrossRef

  60. 60

    Guo-Cai Li, Qing-Hai Ye, Yu-Hua Xue, Hai-Jing Sun, Hai-Jun Zhou, Ning Ren, Hu-Liang Jia, Jiong Shi, Jin-Cai Wu, Chun Dai, Qiong-Zhu Dong, Lun-Xiu Qin. (2010) Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Science 101:12, 2546-2553
    CrossRef

  61. 61

    Gang Chen, Chune Liu, Jin Yao, Qiqin Jiang, Nianhui Chen, Huibin Huang, Jixing Liang, Liantao Li, Lixiang Lin. (2010) Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China. Metabolism 59:12, 1823-1832
    CrossRef

  62. 62

    Zhaoshen Li, Duowu Zou, Xiuqiang Ma, Jie Chen, Xingang Shi, Yanfang Gong, Xiaohua Man, Li Gao, Yanfang Zhao, Rui Wang, Xiaoyan Yan, John Dent, Joseph J Sung, Börje Wernersson, Saga Johansson, Wenbin Liu, Jia He. (2010) Epidemiology of Peptic Ulcer Disease: Endoscopic Results of the Systematic Investigation of Gastrointestinal Disease in China. The American Journal of Gastroenterology 105:12, 2570-2577
    CrossRef

  63. 63

    Lin Zhou, Wuhua Zhou, Liming Wu, Xiaobo Yu, Chunyang Xing, Shusen Zheng. (2010) The association of frequent allelic loss on 17p13.1 with early metastastic recurrence of hepatocellular carcinoma after liver transplantation. Journal of Surgical Oncology 102:7, 802-808
    CrossRef

  64. 64

    Xingqiang Pan, Yongyue Liu, Yonghong Zhang, Xianyu Zhang, Qun Xu, Weijun Tong. (2010) Interaction of the C-344T polymorphism of CYP11b2 gene with body mass index and waist circumference affecting diastolic blood pressure in Chinese Mongolian population. Blood Pressure 19:6, 373-379
    CrossRef

  65. 65

    Ivy Shiue, Jing Fen Zhang, Hisatomi Arima, Ji Guang Wang, Guo Rong Liu, Yue Chun Li, Min Wang, Guo Juan Cheng, Craig S. Anderson, . (2010) Design of the CHina Epidemiology Research in Subarachnoid Haemorrhage (CHERISH) study. International Journal of Stroke 5:6, 493-498
    CrossRef

  66. 66

    Renjie Chen, Guowei Pan, Haidong Kan, Jianguo Tan, Weimin Song, Zhenyu Wu, Xiaohui Xu, Qun Xu, Cheng Jiang, Bingheng Chen. (2010) Ambient air pollution and daily mortality in Anshan, China: A time-stratified case-crossover analysis. Science of The Total Environment 408:24, 6086-6091
    CrossRef

  67. 67

    Xing-Qiang Pan, Yong-Hong Zhang, Yong-Yue Liu, Wei-Jun Tong. (2010) Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population. European Journal of Epidemiology 25:11, 813-821
    CrossRef

  68. 68

    Yining Huang, Ji-Guang Wang, Jade W. Wei, Alexander P. Headley, Lawrence K. S. Wong, Emma L. Heeley, Hisatomi Arima, Jian Sun, Qiang Li, Ming Liu, Zhengyi Li, Li'e Wu, Yan Cheng, Qifang Huang, Shihong Zhang, En Xu, Qidong Yang, Chuanzhen Lu, Craig S. Anderson, . (2010) Research: Age and gender variations in the management of ischaemic stroke in China. International Journal of Stroke 5:5, 351-359
    CrossRef

  69. 69

    Sophia S.C. Chan, Doris Y.P. Leung, Abu S.M. Abdullah, Sue S.T. Lo, Andrew W.C. Yip, Wai-Ming Kok, Sai-Yin Ho, Tai-Hing Lam. (2010) Smoking-Cessation and Adherence Intervention Among Chinese Patients with Erectile Dysfunction. American Journal of Preventive Medicine 39:3, 251-258
    CrossRef

  70. 70

    Ye Rong, Fiona Turnbull, Anushka Patel, Xin Du, Yangfeng Wu, Runlin Gao. (2010) Clinical Pathways for Acute Coronary Syndromes in China. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 9:3, 134-139
    CrossRef

  71. 71

    Fuqiang Cui, Li Li, Stephen C. Hadler, Fuzhen Wang, Hui Zheng, Yuansheng Chen, Xiaohong Gong, Yvan J. Hutin, K. Lisa Cairns, Xiaofeng Liang, Weizhong Yang. (2010) Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992–2005. Vaccine 28:37, 5973-5978
    CrossRef

  72. 72

    Bin Gao, Yihua Sun, Junhua Zhang, Yan Ren, Rong Fang, Xiangkun Han, Lei Shen, Xin-yuan Liu, William Pao, Haiquan Chen, Hongbin Ji. (2010) Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas. Journal of Thoracic Oncology 5:8, 1130-1135
    CrossRef

  73. 73

    Wing-Yee So, Juliana C. N. Chan. 2010. The Role of the Multidisciplinary Team. , 969-983.
    CrossRef

  74. 74

    D. Hu, D. Yu. (2010) Epidemiology of cardiovascular disease in Asian women. Nutrition, Metabolism and Cardiovascular Diseases 20:6, 394-404
    CrossRef

  75. 75

    Tao Xu, Yang Wang, Wei Li, Wei-Wei Chen, Manlu Zhu, Bo Hu, Tao Chen, Bing Liu. (2010) Survey of Prevalence, Awareness, Treatment, and Control of Hypertension Among Chinese Governmental and Institutional Employees in Beijing. Clinical Cardiology 33:6, E66-E72
    CrossRef

  76. 76

    X. Wen, W. Chen, K. M. Gans, S. M. Colby, C. Lu, C. Liang, W. Ling. (2010) Two-year effects of a school-based prevention programme on adolescent cigarette smoking in Guangzhou, China: a cluster randomized trial. International Journal of Epidemiology 39:3, 860-876
    CrossRef

  77. 77

    Yujuan Shan, Ruifang Zhao, Wei Geng, Na Lin, Xiaoxue Wang, Xiaoyan Du, Shuran Wang. (2010) Protective Effect of Sulforaphane on Human Vascular Endothelial Cells Against Lipopolysaccharide-Induced Inflammatory Damage. Cardiovascular Toxicology 10:2, 139-145
    CrossRef

  78. 78

    Colin Farrelly. (2010) Why aging research?. Annals of the New York Academy of Sciences 1197:1, 1-8
    CrossRef

  79. 79

    Tricia M. Peters, Steven C. Moore, Yong Bing Xiang, Gong Yang, Xiao Ou Shu, Ulf Ekelund, Bu-Tian Ji, Yu Ting Tan, Da Ke Liu, Arthur Schatzkin, Wei Zheng, Wong Ho Chow, Charles E. Matthews, Michael F. Leitzmann. (2010) Accelerometer-Measured Physical Activity in Chinese Adults. American Journal of Preventive Medicine 38:6, 583-591
    CrossRef

  80. 80

    Zhaoqing Sun, Liqiang Zheng, Robert Detrano, Xingang Zhang, Changlu Xu, Jue Li, Dayi Hu, Yingxian Sun. (2010) Risk of Progression to Hypertension in a Rural Chinese Women Population with Prehypertension and Normal Blood Pressure. American Journal of Hypertension 23:6, 627-632
    CrossRef

  81. 81

    Zhenyu He, Albert C. S. Chung. (2010) 3-D B-spline Wavelet-Based Local Standard Deviation (BWLSD): Its Application to Edge Detection and Vascular Segmentation in Magnetic Resonance Angiography. International Journal of Computer Vision 87:3, 235-265
    CrossRef

  82. 82

    Kylie J. Lindorff, David J. Hill. (2010) Physicians' role in advancing tobacco control in China. Thoracic Cancer 1:1, 17-22
    CrossRef

  83. 83

    Wenjun Yang, Qi Qi, Heng Zhang, Wenda Xu, Zhiqiang Chen, Li Wang, Yin Wang, Xiaowei Dong, Haiyan Jiao, Zhenghao Huo. (2010) p21 Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer. Annals of Surgical Oncology 17:5, 1453-1458
    CrossRef

  84. 84

    Lorenzo Azzalini, Elisabet Ferrer, Leandra N. Ramalho, Montserrat Moreno, Marlene Domínguez, Jordi Colmenero, Víctor I. Peinado, Joan A. Barberà, Vicente Arroyo, Pere Ginès, Joan Caballería, Ramón Bataller. (2010) Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51:5, 1567-1576
    CrossRef

  85. 85

    S. Yang, Y. H. Khang, S. Harper, G. Davey Smith, D. A. Leon, J. Lynch. (2010) Understanding the Rapid Increase in Life Expectancy in South Korea. American Journal of Public Health 100:5, 896-903
    CrossRef

  86. 86

    Dahai Yu, Jianfeng Huang, Dongsheng Hu, Jichun Chen, Jie Cao, Jianxin Li. (2010) Is an appropriate cutoff of hypertriglyceridemic waist designated for type 2 diabetes among Chinese adults?. Clinical Nutrition 29:2, 192-198
    CrossRef

  87. 87

    Dongling Sun, Jie Cao, Xiaoqing Liu, Ling Yu, Chonghua Yao, Jianxin Li, Dahai Yu, Jing Chen, Jichun Chen, Xigui Wu, Jianfeng Huang, Jiang He, Dongfeng Gu. (2010) Combined Effects of Smoking and Systolic Blood Pressure on Risk of Coronary Heart Disease: A Cohort Study in Chinese Women. Journal of Women's Health 19:4, 713-718
    CrossRef

  88. 88

    Jianmin Yang, Fanghong Lu, Cheng Zhang, Zhendong Liu, Yingxin Zhao, Fei Gao, Shangwen Sun, Yuxia Zhao, Yun Zhang. (2010) Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertension Research 33:4, 331-337
    CrossRef

  89. 89

    Liang-Hao Hu, Zhuan Liao, Rui Gao, Zhao-Shen Li. (2010) Scientific publications in cardiology and cardiovasology journals from Chinese authors in various parts of North Asia: 10-year survey of literature. International Journal of Cardiology 140:3, 304-308
    CrossRef

  90. 90

    Yang, Wenying, Lu, Juming, Weng, Jianping, Jia, Weiping, Ji, Linong, Xiao, Jianzhong, Shan, Zhongyan, Liu, Jie, Tian, Haoming, Ji, Qiuhe, Zhu, Dalong, Ge, Jiapu, Lin, Lixiang, Chen, Li, Guo, Xiaohui, Zhao, Zhigang, Li, Qiang, Zhou, Zhiguang, Shan, Guangliang, He, Jiang, . (2010) Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine 362:12, 1090-1101
    Full Text

  91. 91

    Jun-Jie Xiao, Yi-Han Chen. (2010) Prevalence of cardiovascular diseases in China. Frontiers of Medicine in China 4:1, 16-20
    CrossRef

  92. 92

    Mark I. Neuman, Walter C. Willett, Gary C. Curhan. (2010) Physical Activity and the Risk of Community-acquired Pneumonia in US Women. The American Journal of Medicine 123:3, 281.e7-281.e11
    CrossRef

  93. 93

    Yu Shi, Chunhua Yu, Ailun Luo, Yuguang Huang, David O. Warner. (2010) Perioperative Tobacco Interventions by Chinese Anesthesiologists. Anesthesiology 112:2, 338-346
    CrossRef

  94. 94

    Liqiang Zheng, Zhaoqing Sun, Xingang Zhang, Changlu Xu, Jiajin Li, Meiqiong Li, Lidong Wang, Jue Li, Dayi Hu, Yingxian Sun. (2010) Risk of progression to hypertension across baseline blood pressure in nonhypertensive participants among rural Chinese adults: a prospective study. Journal of Hypertension1
    CrossRef

  95. 95

    Jian Sun, Hong-Mei Xu, Hai-Jun Zhou, Qiong-Zhu Dong, Yue Zhao, Li-Yun Fu, Zhen-Yu Hei, Qing-Hai Ye, Ning Ren, Hu-Liang Jia, Lun-Xiu Qin. (2010) The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 136:1, 1-7
    CrossRef

  96. 96

    Yonghong Zhang, Angela M Thompson, Weijun Tong, Tan Xu, Jing Chen, Li Zhao, Tanika N Kelly, Chung-Shiuan Chen, Jiang He. (2010) Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China. Journal of Hypertension 28:1, 35-40
    CrossRef

  97. 97

    Lydia A. Bazzano, Dongfeng Gu, Megan R. Whelton, Xiqui Wu, Chung-Shiuan Chen, Xiufang Duan, Jing Chen, Ji-Chun Chen, Jiang He. (2010) Body mass index and risk of stroke among Chinese men and women. Annals of Neurology 67:1, 11-20
    CrossRef

  98. 98

    Zhong Chen, Xiaofeng Zhang, Genshan Ma, Qi Qian, Yuyu Yao. (2010) Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population. Molecular Biology Reports 37:1, 207-212
    CrossRef

  99. 99

    Jian-Jun Yan, Na-Ping Tang, Jian-Jin Tang, En-zhi Jia, Ming-Wei Wang, Qi-Ming Wang, Jun Zhu, Zhi-Jian Yang, Lian-sheng Wang, Jun Huang. (2010) Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population. Clinica Chimica Acta 411:1-2, 26-30
    CrossRef

  100. 100

    Chen Zhong, Zhang Luzhan, Ma Genshan, Wang Jiahong, Zhang Xiaoli, Qian Qi. (2010) Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Molecular Biology Reports 37:1, 7-12
    CrossRef

  101. 101

    Tobias Kurth, Michael F. Leitzmann. (2010) Awakening of the sleeping giant: Obesity and stroke in China. Annals of Neurology 67:1, 1-2
    CrossRef

  102. 102

    Jian-Jun Guo, En Xu, Qing-Yuan Lin, Guo-Ling Zeng, Hai-Feng Xie. (2009) Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke. Neuroscience Bulletin 25:6, 383-390
    CrossRef

  103. 103

    Hailei Wu, Jiqu Xu, Lang Zhuo, Lingcai Han, Wei Bao, Shuang Rong, Ping Yao, Chenjiang Ying, Liegang Liu. (2009) Comparison of Risk Factors Associated With Hypertension Subtypes by Classification Tree Method in Tongshan County of Jiangsu Province, China. American Journal of Hypertension 22:12, 1287-1294
    CrossRef

  104. 104

    Xiaofeng Liang, Shengli Bi, Weizhong Yang, Longde Wang, Gang Cui, Fuqiang Cui, Yong Zhang, Jianhua Liu, Xiaohong Gong, Yuansheng Chen, Fuzhen Wang, Hui Zheng, Feng Wang, Jing Guo, Zhiyuan Jia, Jingchen Ma, Huaqing Wang, Huiming Luo, Li Li, Shuigao Jin, Stephen C. Hadler, Yu Wang. (2009) Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination. Vaccine 27:47, 6550-6557
    CrossRef

  105. 105

    Jiang He, Dongfeng Gu, Jing Chen, Xigui Wu, Tanika N Kelly, Jian-feng Huang, Ji-chun Chen, Chung-Shiuan Chen, Lydia A Bazzano, Kristi Reynolds, Paul K Whelton, Michael J Klag. (2009) Premature deaths attributable to blood pressure in China: a prospective cohort study. The Lancet 374:9703, 1765-1772
    CrossRef

  106. 106

    K. Luo, Z. Liu, P. Karayiannis. (2009) Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma. Journal of Viral Hepatitis
    CrossRef

  107. 107

    Xin-Min Pan, Dong-Ri Li, Lan Yang, En-Yin Wang, Tian-Yi Chen, Ya-Ju Liu, Min Liu, Zhi-Gang Liao. (2009) No Association Between Vitamin D Receptor Polymorphisms and Coronary Artery Disease in a Chinese Population. DNA and Cell Biology 28:10, 521-525
    CrossRef

  108. 108

    Zhong Chen, Genshan Ma, Qi Qian, Yuyu Yao, Yi Feng, Chengchun Tang. (2009) Toll-like receptor 8 polymorphism and coronary artery disease. Molecular Biology Reports 36:7, 1897-1901
    CrossRef

  109. 109

    Wei-Wei Zhang, Chun-Yu Liu, Yan-Jiang Wang, Zhi-Qiang Xu, Yang Chen, Hua-Dong Zhou. (2009) Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. Journal of Neurology 256:9, 1493-1499
    CrossRef

  110. 110

    SHU ZHANG. (2009) Sudden Cardiac Death in China. Pacing and Clinical Electrophysiology 32:9, 1159-1162
    CrossRef

  111. 111

    F. Cao, D. Sun, C. Li, K. Narsinh, L. Zhao, X. Li, X. Feng, J. Zhang, Y. Duan, J. Wang, D. Liu, H. Wang. (2009) Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal 30:16, 1986-1994
    CrossRef

  112. 112

    R. Wang, Y. Zhao, X. He, X. Ma, X. Yan, Y. Sun, W. Liu, Z. Gu, J. Zhao, J. He. (2009) Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health 123:8, 534-539
    CrossRef

  113. 113

    Ashkan Akasheh, Yangfeng Wu, Yi Li, Laurie D. Dustin, Nathan D. Wong, Julius M. Gardin, Stanley P. Azen, Robert C. Detrano. (2009) Association of Blood Pressure With Left Ventricular Mass in Untreated Hypertensives in Rural Yunnan Province. American Journal of Hypertension 22:7, 730-734
    CrossRef

  114. 114

    Nawi Ng, Volker Winkler, Hoang Van Minh, Fikru Tesfaye, Stig Wall, Heiko Becher. (2009) Predicting lung cancer death in Africa and Asia: differences with WHO estimates. Cancer Causes & Control 20:5, 721-730
    CrossRef

  115. 115

    Chin-Lan Yen, Hsio-Yun Chang, Shang-Yi Huang, Yung-Chien Huang, Chin-Ming Jeng. (2009) Combination of tissue harmonic sonography, real-time spatial compound sonography and adaptive image processing technique for the detection of carotid plaques and intima-medial thickness. European Journal of Radiology 71:1, 11-16
    CrossRef

  116. 116

    Jin-Xin Li, Bao-Peng Tang, Hui-Ping Sun, Min Feng, Zu-Heng Cheng, Wen-Quan Niu. (2009) Interacting contribution of the five polymorphisms in three genes of Hsp70 family to essential hypertension in Uygur ethnicity. Cell Stress and Chaperones 14:4, 355-362
    CrossRef

  117. 117

    Lei Wang, Min-zhou Zhang, Guang Yang. (2009) Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction. Chinese Journal of Integrative Medicine 15:3, 233-235
    CrossRef

  118. 118

    Lydia A. Bazzano, Dongfeng Gu, Kristi Reynolds, Jing Chen, Xiqui Wu, Chiung-Shiuan Chen, Xiufang Duan, Jichun Chen, Jiang He. (2009) Alcohol consumption and risk of coronary heart disease among Chinese men. International Journal of Cardiology 135:1, 78-85
    CrossRef

  119. 119

    Lam Lau, Ying Lau, Ying Hon Lau. (2009) Prevalence and correlates of influenza vaccination among non-institutionalized elderly people: An exploratory cross-sectional survey. International Journal of Nursing Studies 46:6, 768-777
    CrossRef

  120. 120

    Michael E. Sughrue, J. Mocco, Willam J. Mack, Andrew F. Ducruet, Ricardo J. Komotar, Ruth L. Fischbach, Thomas E. Martin, E. Sander Connolly. (2009) Bioethical Considerations in Translational Research: Primate Stroke. The American Journal of Bioethics 9:5, 3-12
    CrossRef

  121. 121

    Ling Zhang, Ming Yang, Yan Song, Zhongwei Sun, Yi Peng, Kai Qu, Haibo Zhu. (2009) Antihypertensive effect of 3,3,5,5-tetramethyl-4-piperidone, a new compound extracted from Marasmius androsaceus. Journal of Ethnopharmacology 123:1, 34-39
    CrossRef

  122. 122

    Li Yang, Huaijun Zhu, Bo Zhou, Haijuan Gu, Hongli Yan, Naping Tang, Hanzhang Dong, Qingmin Sun, Rihong Cong, Guoyu Chen, Bin Wang. (2009) The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population. Digestive Diseases and Sciences 54:5, 1021-1028
    CrossRef

  123. 123

    Chi Pang Wen, Ting Yuan David Cheng, Shan Pou Tsai, Hui Ting Chan, Hui Ling Hsu, Chih Cheng Hsu, Michael P Eriksen. (2009) Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutrition 12:04, 497
    CrossRef

  124. 124

    Ye Lin, Zhe Zheng, Yan Li, Xin Yuan, Jianfeng Hou, Shiju Zhang, Hongguang Fan, Yang Wang, Wei Li, Shengshou Hu. (2009) Impact of Renal Dysfunction on Long-Term Survival After Isolated Coronary Artery Bypass Surgery. The Annals of Thoracic Surgery 87:4, 1079-1084
    CrossRef

  125. 125

    Yin Ruixing, Li Hui, Wu Jinzhen, Lin Weixiong, Yang Dezhai, Pan Shangling, Huang Jiandong, Long Xiuyan. (2009) Association of diet and lifestyle with blood pressure in the Guangxi Hei Yi Zhuang and Han populations. Public Health Nutrition 12:04, 553
    CrossRef

  126. 126

    Tsogzolmaa Dorjgochoo, Xiao Ou Shu, Xianglan Zhang, Honglan Li, Gong Yang, Lifeng Gao, Hui Cai, Yu-Tang Gao, Wei Zheng. (2009) Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. Journal of Hypertension 27:3, 468-475
    CrossRef

  127. 127

    Yihong Sun, Dayi Hu, Kuibao Li, Ziqiang Zhou. (2009) Predictors of Stroke Risk in Native Chinese with Nonrheumatic Atrial Fibrillation: Retrospective Investigation of Hospitalized Patients. Clinical Cardiology 32:2, 76-81
    CrossRef

  128. 128

    Geng-Wen Huang, Yi-Ming Tao, Xiang Ding. (2009) Endocan Expression Correlated with Poor Survival in Human Hepatocellular Carcinoma. Digestive Diseases and Sciences 54:2, 389-394
    CrossRef

  129. 129

    Faming Zhang, Gui Ren, Yuanyuan Lu, Bin Jin, Jun Wang, Xiong Chen, Zhenxiong Liu, Kai Li, Yongzhan Nie, Xin Wang, Daiming Fan. (2009) Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: A novel cancer biomarker. Cancer Letters 274:2, 250-258
    CrossRef

  130. 130

    X. Qin, R. Jackson, R. Marshall, L. Lee, W. Cao, S. Zhan, Y. Hu. (2009) Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China. European Journal of Cardiovascular Prevention & Rehabilitation 16:1, 96-101
    CrossRef

  131. 131

    Yingjuan Cao, Patricia M Davidson, Michelle DiGiacomo. (2009) Cardiovascular disease in China: an urgent need to enhance the nursing role to improve health outcomes. Journal of Clinical Nursing
    CrossRef

  132. 132

    Wan C. TAN, Paul SEALE, Mary IP, Young-Soo SHIM, Chi-Huei CHIANG, Tze-Pin NG, John ABISHEGANADAN, Suchai CHAROENRATANAKUL, Teresita DeGUIA, Aziah MAHAYIDDIN, Hardiato MANGUNNEGORO, Yong-Jian XU, Nan-Shan ZHONG. (2009) Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology 14:1, 90-97
    CrossRef

  133. 133

    Zhengming Chen, Lixin Jiang. (2009) Changing strategies in the management of acute myocardial infarction in modern China. CVD Prevention and Control 4:1, 9-18
    CrossRef

  134. 134

    C.M. Schooling. (2009) Risk factors for the metabolic syndrome in contemporary China. CVD Prevention and Control 4:1, 41-50
    CrossRef

  135. 135

    Haidong Kan, Wei Huang, Bingheng Chen, Ni Zhao. (2009) Impact of outdoor air pollution on cardiovascular health in Mainland China. CVD Prevention and Control 4:1, 71-78
    CrossRef

  136. 136

    Xiaoli Chen, Youfa Wang. (2009) The epidemic of diabetes and its impact on cardiovascular health in contemporary China. CVD Prevention and Control 4:1, 27-40
    CrossRef

  137. 137

    Pannuru Padmavathi, Vaddi Damodara Reddy, Nallanchakravarthula Varadacharyulu. (2009) Influence of Chronic Cigarette Smoking on Serum Biochemical Profile in Male Human Volunteers. JOURNAL OF HEALTH SCIENCE 55:2, 265-270
    CrossRef

  138. 138

    Sung Hoon Kim, Young-Hwa Chung, Soo Hyun Yang, Jeong A Kim, Myoung Kuk Jang, Sung Eun Kim, Danbi Lee, Sae Hwan Lee, Don Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh. (2009) Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization. The Korean Journal of Hepatology 15:3, 320
    CrossRef

  139. 139

    Jiang Xie, Dayi Hu, Xian Wang, Yali Luo, Jinwen Wang. (2009) Smoking State Determined by Cotinine and Arterial Stiffness. Circulation Journal 73:8, 1537-1542
    CrossRef

  140. 140

    Rohina Joshi, Stephen Jan, Yangfeng Wu, Stephen MacMahon. (2008) Global Inequalities in Access to Cardiovascular Health Care. Journal of the American College of Cardiology 52:23, 1817-1825
    CrossRef

  141. 141

    Neil J. Stone. (2008) Clinical Trials Report. Current Atherosclerosis Reports 10:6, 457-459
    CrossRef

  142. 142

    Bing-Sheng Sun, Qiong-Zhu Dong, Qing-Hai Ye, Hai-Jing Sun, Hu-Liang Jia, Xiao-Qun Zhu, Dao-Yong Liu, Jie Chen, Qiong Xue, Hai-Jun Zhou, Ning Ren, Lun-Xiu Qin. (2008) Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 48:6, 1834-1842
    CrossRef

  143. 143

    Ting-Yuan David Cheng, Sung-Feng Wen, Brad C. Astor, Xuguang (Grant) Tao, Jonathan M. Samet, Chi Pang Wen. (2008) Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan. American Journal of Kidney Diseases 52:6, 1051-1060
    CrossRef

  144. 144

    E. Linos, D. Spanos, B. A. Rosner, K. Linos, T. Hesketh, J. D. Qu, Y.-T. Gao, W. Zheng, G. A. Colditz. (2008) Effects of Reproductive and Demographic Changes on Breast Cancer Incidence in China: A Modeling Analysis. JNCI Journal of the National Cancer Institute 100:19, 1352-1360
    CrossRef

  145. 145

    Ning-L. Sun, Jun-R. Zhu, Yanxing Zhao, Ying-M. Tu. (2008) Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension. Current Medical Research and Opinion 24:10, 2863-2871
    CrossRef

  146. 146

    Yan Zhang, Weiwei Xu, Xiaoyu Li, Yibo Tang, Peng Xie, Yong Ji, Leming Fan, Qi Chen. (2008) ASSOCIATION BETWEEN PPARGC1A GENE POLYMORPHISMS AND CORONARY ARTERY DISEASE IN A CHINESE POPULATION. Clinical and Experimental Pharmacology and Physiology 35:10, 1172-1177
    CrossRef

  147. 147

    Yonghong Zhang, Kathleen H Reilly, Weijun Tong, Tan Xu, Jing Chen, Lydia A Bazzano, Dawei Qiao, Zhong Ju, Chung-Shiuan Chen, Jiang He. (2008) Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. Journal of Hypertension 26:7, 1446-1452
    CrossRef

  148. 148

    Rachel P. Wildman, Dongfeng Gu, Paul Muntner, Xiqui Wu, Kristi Reynolds, Xiufang Duan, Chung-Shiuan Chen, Guangyong Huang, Lydia A. Bazzano, Jiang He. (2008) Trends in Overweight and Obesity in Chinese Adults: Between 1991 and 1999–2000. Obesity 16:6, 1448-1453
    CrossRef

  149. 149

    Hao Zhang, Ying-jie Wei, Sheng-shou Hu. (2008) Intraoperative Cell Transplantation for Congestive Heart Failure: Experience in China. Seminars in Thoracic and Cardiovascular Surgery 20:2, 126-130
    CrossRef

  150. 150

    Chun-song Hu. (2008) RT-ABCDE Strategy for management and prevention of human diseases. Chinese Journal of Integrative Medicine 14:2, 147-150
    CrossRef

  151. 151

    Huaguang Zheng, Liping Liu, Haixin Sun, Xianwei Wang, Yilong Wang, Yong Zhou, Jingjing Lu, Xingquan Zhao, Chunxue Wang, Kehui Dong, Zhonghua Yang, Yongjun Wang. (2008) Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China. Neurological Research 30:4, 370-376
    CrossRef

  152. 152

    Jing Chen, Dongfeng Gu, Seamus P Whelton, Xigui Wu, Chung-Shiuan Chen, Xiufang Duan, Jianfeng Huang, Jichun Chen, Tanika N Kelly, Lotuce Lee Hamm, Jiang He. (2008) Blood pressure and mortality among Chinese patients with cardiovascular disease. Journal of Hypertension 26:5, 859-865
    CrossRef

  153. 153

    Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An, Ying Shuai, Bo Zhang, Jingling Zhang, Theodore J Thompson, Robert B Gerzoff, Gojka Roglic, Yinghua Hu, Peter H Bennett. (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet 371:9626, 1783-1789
    CrossRef

  154. 154

    Xing Wu, Jin Hu, Liangfu Zhuo, Chaowei Fu, Guozhen Hui, Yehan Wang, Weizhong Yang, Liangzhu Teng, Sitin Lu, Gengsheng Xu. (2008) Epidemiology of Traumatic Brain Injury in Eastern China, 2004: A Prospective Large Case Study. The Journal of Trauma: Injury, Infection, and Critical Care 64:5, 1313-1319
    CrossRef

  155. 155

    Tsung O. Cheng. (2008) Cardiology in contemporary China: An update. International Journal of Cardiology 126:2, 147-159
    CrossRef

  156. 156

    Gabriel W. Yip, Cheuk-Man Yu. 2008. Assessment of Diastolic Heart Failure. , 89-101.
    CrossRef

  157. 157

    Brian Tomlinson, Han Bing Deng, G Neil Thomas. (2008) Prevalence of obesity amongst Chinese populations revisited. Future Lipidology 3:2, 139-152
    CrossRef

  158. 158

    Dongfeng Gu, Tanika N. Kelly, Xigui Wu, Jing Chen, Xiufang Duan, Jian-Feng Huang, Ji-Chun Chen, Paul K. Whelton, Jiang He. (2008) Blood Pressure and Risk of Cardiovascular Disease in Chinese Men and Women. American Journal of Hypertension 21:3, 265-272
    CrossRef

  159. 159

    John D. Cantwell. (2008) Cardiovascular Disease and Olympic Games in China. The American Journal of Cardiology 101:4, 542-543
    CrossRef

  160. 160

    Chun-song Hu. (2008) RT-ABCDE Strategy for management and prevention of human diseases. Chinese Journal of Integrative Medicine
    CrossRef

  161. 161

    R. Mao, X. Li, B. Stanton, J. Wang, Y. Hong, H. Zhang, X. Chen. (2008) Psychosocial correlates of cigarette smoking among college students in China. Health Education Research 24:1, 105-118
    CrossRef

  162. 162

    XJ Ma, C Lin, W Zhen. (2008) Cancer care in China: A general review. Biomedical Imaging and Intervention Journal 4:3,
    CrossRef

  163. 163

    Wei Zhang, Ai-Jun Liu, Wuliya Yi-Ming, Jian-Guo Liu, Fu-Ming Shen, Ding-Feng Su. (2008) PRESSOR AND NON-PRESSOR EFFECTS OF SODIUM LOADING ON STROKE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology 35:1, 83-88
    CrossRef

  164. 164

    Jihong HU, Yangfeng WU, Liancheng ZHAO, Ying LI, Beifan ZHOU. (2008) Natural Variances in Blood Pressure Category among Chinese Adults. Hypertension Research 31:5, 905-911
    CrossRef

  165. 165

    Bernard M.Y Cheung, Nelson M.S Wat, Y. B Man, Sidney Tam, C. H Cheng, Gabriel M Leung, Jean Woo, Edward D Janus, C. P Lau, T. H Lam, Karen S.L Lam. (2008) Relationship Between the Metabolic Syndrome and the Development of Hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). American Journal of Hypertension 21:1, 17-22
    CrossRef

  166. 166

    Ruixing Yin, Hui Li, Jinzhen Wu, Weixiong Lin, Dezhai Yang, Shangling Pan, Jiandong Huang, Xiuyan Long. (2007) Effects of alcohol consumption and other lifestyle behaviors on blood pressure for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. Alcohol 41:8, 541-550
    CrossRef

  167. 167

    Wenquan Niu, Yue Qi, Shuqin Hou, Wenyu Zhou, Changchun Qiu. (2007) Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Translational Research 150:6, 374-380
    CrossRef

  168. 168

    Lydia A. Bazzano, Dongfeng Gu, Kristi Reynolds, Xiqui Wu, Chiung-Shiuan Chen, Xiufang Duan, Jing Chen, Rachel P. Wildman, Michael J. Klag, Jiang He. (2007) Alcohol consumption and risk for stroke among Chinese men. Annals of Neurology 62:6, 569-578
    CrossRef

  169. 169

    Gary T. C. Ko, Joyce S. F. Tang. (2007) Waist Circumference and BMI Cut-off Based on 10-year Cardiovascular Risk: Evidence for “Central Pre-Obesity”**. Obesity 15:11, 2832-2839
    CrossRef

  170. 170

    Michelle Heys, C Mary Schooling, Chaoqiang Jiang, Benjamin J. Cowling, Xiangqian Lao, Weisen Zhang, Kar Keung Cheng, Peymane Adab, G Neil Thomas, Tai Hing Lam, Gabriel M. Leung. (2007) Age of Menarche and the Metabolic Syndrome in China. Epidemiology 18:6, 740-746
    CrossRef

  171. 171

    Gang LING, Ai-jun LIU, Fu-ming SHEN, Guo-jun CAI, Jian-guo LIU, Ding-feng SU. (2007) Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats. Acta Pharmacologica Sinica 28:11, 1755-1760
    CrossRef

  172. 172

    T. Yasuhara, K. Hara, M. Maki, N. Matsukawa, H. Fujino, I. Date, C.V. Borlongan. (2007) Lack of exercise, via hindlimb suspension, impedes endogenous neurogenesis. Neuroscience 149:1, 182-191
    CrossRef

  173. 173

    Wang-Hong Xu, Xiang-Lan Zhang, Yu-Tang Gao, Yong-Bing Xiang, Li-Feng Gao, Wei Zheng, Xiao-Ou Shu. (2007) Joint effect of cigarette smoking and alcohol consumption on mortality. Preventive Medicine 45:4, 313-319
    CrossRef

  174. 174

    Rui-fang Wu, Min Dai, You-lin Qiao, Gary M. Clifford, Zhi-hua Liu, Annie Arslan, Ni Li, Ju-fang Shi, Peter J.F. Snijders, Chris J.L.M. Meijer, Silvia Franceschi. (2007) Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. International Journal of Cancer 121:6, 1306-1311
    CrossRef

  175. 175

    Anoop Misra, Om P. Ganda. (2007) Migration and its impact on adiposity and type 2 diabetes. Nutrition 23:9, 696-708
    CrossRef

  176. 176

    Rosenzweig, Anthony, . (2007) Scanning the Genome for Coronary Risk. New England Journal of Medicine 357:5, 497-499
    Full Text

  177. 177

    Yuan Jiang, Michael K. Ong, Elisa K. Tong, Yan Yang, Yi Nan, Quan Gan, Teh-wei Hu. (2007) Chinese Physicians and Their Smoking Knowledge, Attitudes, and Practices. American Journal of Preventive Medicine 33:1, 15-22
    CrossRef

  178. 178

    Benyan Luo, Yanwen Wang, Kang Wang. (2007) Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clinica Chimica Acta 380:1-2, 238-240
    CrossRef

  179. 179

    Jing Liu, Scott M. Grundy, Wei Wang, Sidney C. Smith, Gloria Lena Vega, Zhaosu Wu, Zhechun Zeng, Wenhua Wang, Dong Zhao. (2007) Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. American Heart Journal 153:4, 552-558
    CrossRef

  180. 180

    Henry L-Y Chan, Vincent W-S Wong. (2007) Can dietetic intervention for obesity ever succeed in real life?. Journal of Gastroenterology and Hepatology 22:4, 459-460
    CrossRef

  181. 181

    Dongfeng Gu, Rachel P Wildman, Xiqui Wu, Kristi Reynolds, Jianfeng Huang, Chung-Shiuan Chen, Jiang He. (2007) Incidence and predictors of hypertension over 8 years among Chinese men and women. Journal of Hypertension 25:3, 517-523
    CrossRef

  182. 182

    Yongli Guo, Xuemei Zhang, Wen Tan, Xiaoping Miao, Tong Sun, Dan Zhao, Dongxin Lin. (2007) Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Pharmacogenetics and Genomics 17:3, 197-205
    CrossRef

  183. 183

    Song Guo, Da Fang Chen, Dong Feng Zhou, Hong Qiang Sun, Gui Ying Wu, Colin N. Haile, Therese A. Kosten, Thomas R. Kosten, Xiang Yang Zhang. (2007) Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology 190:4, 449-456
    CrossRef

  184. 184

    W.J. Elliott. (2007) Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. Yearbook of Cardiology 2007, 33-36
    CrossRef

  185. 185

    George K.K. Lau. (2007) Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?. Journal of Hepatology 46:1, 6-8
    CrossRef

  186. 186

    Ramón Bataller. (2006) Time to ban smoking in patients with chronic liver diseases. Hepatology 44:6, 1394-1396
    CrossRef

  187. 187

    Kevin A. Kerber, Gregory T. Whitman, Devin L. Brown, Robert W. Baloh. (2006) Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI. Journal of the Neurological Sciences 250:1-2, 33-38
    CrossRef

  188. 188

    Hui Zhang, Qing-Hai Ye, Ning Ren, Lei Zhao, Yan-Fang Wang, Xin Wu, Hui-Chuan Sun, Lu Wang, Bo-Heng Zhang, Yin-Kun Liu, Zhao-You Tang, Lun-Xiu Qin. (2006) The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 132:11, 709-717
    CrossRef

  189. 189

    Y Wang, J Chen, K Wang, C L Edwards. (2006) Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. Journal of Human Hypertension 20:11, 898-900
    CrossRef

  190. 190

    Luis A. Watanabe, Meng Wei, Ningling Sun, Dongsoo Kim, Chern-En Chiang, Yuannan Ke, Chuen‐Den Tseng, Ricardo Coloma, M. Vala, R. Massaad, P. Feig, S. Guptha. (2006) Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial. Current Medical Research and Opinion 22:10, 1955-1964
    CrossRef

  191. 191

    Jee, Sun Ha, Sull, Jae Woong, Park, Jungyong, Lee, Sang-Yi, Ohrr, Heechoul, Guallar, Eliseo, Samet, Jonathan M., . (2006) Body-Mass Index and Mortality in Korean Men and Women. New England Journal of Medicine 355:8, 779-787
    Full Text

  192. 192

    S.L. Hui, L.W. Chu, J.S.M. Peiris, K.H. Chan, D. Chu, W. Tsui. (2006) Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 24:25, 5371-5380
    CrossRef

  193. 193

    Tazeen H Jafar. (2006) Hypertension and kidney disease in Asia. Current Opinion in Nephrology and Hypertension 15:3, 291-295
    CrossRef

  194. 194

    (2006) Major Causes of Death in China. New England Journal of Medicine 354:8, 874-876
    Full Text

  195. 195

    (2006) The Evolving Chinese Health Care System. New England Journal of Medicine 354:8, 876-876
    Full Text

  196. 196

    Yu-Hua Sun, Yue-Jin Yang, Wei-Dong Pei, Yong-Jian Wu, Run-Lin Gao. (2006) Patients With Low High-Density Lipoprotein-Cholesterol or Smoking are More Likely to Develop Myocardial Infarction Among Subjects With a Visible Lesion or Stenosis in Coronary Artery. Circulation Journal 70:12, 1602-1605
    CrossRef

  197. 197

    Daniel Redwood, C. Norman Shealy. (2005) The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-Term Health. Two Reviews The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-Term Health. T. Colin Campbell , Ph.D., and Thomas M. Campbell II, Dallas; Benbella Books, 2004 , 368 pages, ISBN 1-932100-38-5, $24.95 hardcover. The Journal of Alternative and Complementary Medicine 11:6, 1117-1119
    CrossRef

Letters